HCA Healthcare, Inc. (NYSE:HCA) Receives $280.21 Consensus PT from Brokerages

HCA Healthcare, Inc. (NYSE:HCAGet Rating) has earned a consensus rating of “Buy” from the twenty-five analysts that are presently covering the stock, MarketBeat reports. Eight equities research analysts have rated the stock with a hold recommendation, fifteen have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $280.21.

HCA has been the subject of several analyst reports. Wells Fargo & Company initiated coverage on HCA Healthcare in a report on Monday, March 28th. They issued an “equal weight” rating and a $267.00 target price for the company. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Wednesday, April 6th. Mizuho upped their price target on HCA Healthcare from $275.00 to $290.00 and gave the stock a “buy” rating in a report on Monday, December 20th. Cowen cut their price target on HCA Healthcare from $302.00 to $265.00 and set an “outperform” rating for the company in a report on Friday, January 28th. Finally, JPMorgan Chase & Co. lowered HCA Healthcare from an “overweight” rating to a “neutral” rating and set a $270.00 price target for the company. in a report on Tuesday, December 21st.

Shares of HCA Healthcare stock traded up $2.30 during trading on Monday, hitting $260.94. 1,045,896 shares of the stock traded hands, compared to its average volume of 1,485,653. The stock has a market cap of $78.81 billion, a P/E ratio of 12.28, a PEG ratio of 1.43 and a beta of 1.60. The company has a debt-to-equity ratio of 23.06, a quick ratio of 1.21 and a current ratio of 1.41. HCA Healthcare has a twelve month low of $190.38 and a twelve month high of $272.26. The company has a fifty day moving average price of $254.91 and a two-hundred day moving average price of $248.49.

HCA Healthcare (NYSE:HCAGet Rating) last posted its earnings results on Thursday, January 27th. The company reported $4.42 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $4.55 by ($0.13). HCA Healthcare had a return on equity of 303.35% and a net margin of 11.84%. The company had revenue of $15.06 billion during the quarter, compared to analyst estimates of $15.41 billion. During the same quarter last year, the firm posted $4.13 earnings per share. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year. On average, equities research analysts expect that HCA Healthcare will post 18.78 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 31st. Shareholders of record on Thursday, March 17th were paid a $0.56 dividend. The ex-dividend date was Wednesday, March 16th. This represents a $2.24 dividend on an annualized basis and a yield of 0.86%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.48. HCA Healthcare’s payout ratio is currently 10.54%.

HCA Healthcare declared that its board has approved a share repurchase program on Thursday, January 27th that allows the company to repurchase $8.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 10.9% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board believes its shares are undervalued.

In other news, SVP Joseph A. Sowell III sold 11,522 shares of the company’s stock in a transaction on Friday, March 11th. The stock was sold at an average price of $269.00, for a total transaction of $3,099,418.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider A Bruce Moore, Jr. sold 20,633 shares of the company’s stock in a transaction on Wednesday, February 16th. The shares were sold at an average price of $244.01, for a total value of $5,034,658.33. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by insiders.

Large investors have recently added to or reduced their stakes in the business. Equitec Proprietary Markets LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $26,000. Amplius Wealth Advisors LLC bought a new position in HCA Healthcare during the 4th quarter worth $27,000. JJJ Advisors Inc. increased its stake in shares of HCA Healthcare by 96.7% in the 3rd quarter. JJJ Advisors Inc. now owns 118 shares of the company’s stock valued at $29,000 after purchasing an additional 58 shares during the last quarter. PYA Waltman Capital LLC bought a new position in shares of HCA Healthcare in the 4th quarter valued at $31,000. Finally, Ellevest Inc. grew its position in HCA Healthcare by 1,172.7% during the 4th quarter. Ellevest Inc. now owns 140 shares of the company’s stock worth $36,000 after acquiring an additional 129 shares during the last quarter. 66.36% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.